Financials data is unavailable for this security.
View more
Year on year Allovir Inc 's net income fell 12.87% from a loss of 168.71m to a larger loss of 190.42m despite flat revenues.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -67.85% |
---|---|
Return on equity | -80.33% |
Return on investment | -73.72% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Allovir Inc fell by 15.97m. Cash Flow from Financing totalled 70.50m or -- of revenues. In addition the company used 124.45m for operations while cash from investing totalled 37.99m.
Cash flow per share | -1.22 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.04 |
---|---|
Tangible book value per share | 1.04 |
More ▼
Balance sheet in USDView more
Current ratio | 55.08 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼